FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 323 of 323

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
VIVS Nasdaq VivoSim Labs, Inc. 2836
VKTX Nasdaq Viking Therapeutics, Inc. 2836
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2836
VSTM Nasdaq Verastem, Inc. 2836
VTRLY Over the counter Vitrolife AB (publ) 2836
VTVT Nasdaq vTv Therapeutics Inc. 2836
VYGR Nasdaq Voyager Therapeutics, Inc. 2836
XAIR Nasdaq Beyond Air, Inc. 2836
XBIT Nasdaq XBiotech Inc. 2836
XCUR Nasdaq Exicure, Inc. 2836
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2836
XGN Nasdaq Exagen Inc. 2836
XLO Nasdaq Xilio Therapeutics, Inc. 2836
XNCR Nasdaq Xencor, Inc. 2836
XOMA Nasdaq XOMA Royalty Corporation 2836
XTNT NYSE American Xtant Medical Holdings, Inc. 2836
YDES Nasdaq YD Bio Limited 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZEOX Over the counter Zeo ScientifiX, Inc. 2836
ZLDPY Over the counter Zealand Pharma A/S 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
ZURA Nasdaq Zura Bio Limited 2836
ZYME Nasdaq Zymeworks Inc. 2836
Results 300 through 323 of 323